Champions Oncology reported a record quarterly service revenue of $14.9 million for the second quarter of fiscal 2026.
Total revenue increased by 11% to $15 million in the same period.
The company's net income was $237,000 for the quarter.
Total Revenue Growth
Total revenue increased by 11% to $15 million in the second quarter of fiscal 2026.
Oncology Services Margin
Oncology services margin reached 52% with a profit of $7.8 million.
Adjusted EBITDA Performance
Adjusted EBITDA was $843,000 for the second quarter of fiscal 2026.
- Champions Oncology remains on track to deliver year-over-year revenue growth and positive adjusted EBITDA for the fiscal year.
- The company's strategic investments in data platform expansion and business development are expected to contribute to long-term growth and shareholder value.
With a strong quarterly performance and positive outlook for the fiscal year, Champions Oncology is poised for continued growth and value creation for shareholders.